Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Roehl

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
The Journal of Urology|November 17, 2009
Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?Stacy Loeb, Kimberly A Roehl, Brian T Helfand, et al.
BJU International|February 3, 2012
Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancerStacy Loeb, E Jeffrey Metter, Donghui Kan, et al.
The Journal of Urology|July 12, 2005
Results of compliance with prostate cancer screening guidelinesRobert L Grubb, Kimberly A Roehl, Jo Ann V Antenor, et al.
Urology|December 8, 2009
Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocolsC Shad Thaxton, Stacy Loeb, Kimberly A Roehl, et al.
The Journal of Urology|October 24, 2002
Screening for prostate cancer in high risk populationsWilliam J Catalona, Jo Ann V Antenor, Kimberly A Roehl, et al.
Urology|June 24, 2008
PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressivenessStacy Loeb, Douglas E Sutherland, Anthony V D'Amico, et al.
The Journal of Urology|December 14, 2004
Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonographyStacy Loeb, Misop Han, Kimberly A Roehl, et al.
The Thoracic and Cardiovascular Surgeon|November 15, 2011
Inflammatory response in transapical transaortic valve replacementA Goetzenich, A Roehl, J Spillner, et al.
Clinical Journal of Oncology Nursing|March 19, 2019
Dermatologic Toxicities: A Chart Review of Clinical Management Among Patients With Metastatic Colorectal Cancer Treated With PanitumumabKimberly A Lowe, Laura Sangaré, Kimberly A Roehl, et al.
Urology|January 31, 2006
More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effectsThomas L Jang, Misop Han, Kimberly A Roehl, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Urology|November 17, 2009
Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?Stacy Loeb, Kimberly A Roehl, Brian T Helfand, et al.
BJU International|February 3, 2012
Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancerStacy Loeb, E Jeffrey Metter, Donghui Kan, et al.
The Journal of Urology|July 12, 2005
Results of compliance with prostate cancer screening guidelinesRobert L Grubb, Kimberly A Roehl, Jo Ann V Antenor, et al.
Urology|December 8, 2009
Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocolsC Shad Thaxton, Stacy Loeb, Kimberly A Roehl, et al.
The Journal of Urology|October 24, 2002
Screening for prostate cancer in high risk populationsWilliam J Catalona, Jo Ann V Antenor, Kimberly A Roehl, et al.
Urology|June 24, 2008
PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressivenessStacy Loeb, Douglas E Sutherland, Anthony V D'Amico, et al.
The Journal of Urology|December 14, 2004
Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonographyStacy Loeb, Misop Han, Kimberly A Roehl, et al.
The Thoracic and Cardiovascular Surgeon|November 15, 2011
Inflammatory response in transapical transaortic valve replacementA Goetzenich, A Roehl, J Spillner, et al.
Clinical Journal of Oncology Nursing|March 19, 2019
Dermatologic Toxicities: A Chart Review of Clinical Management Among Patients With Metastatic Colorectal Cancer Treated With PanitumumabKimberly A Lowe, Laura Sangaré, Kimberly A Roehl, et al.
Urology|January 31, 2006
More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effectsThomas L Jang, Misop Han, Kimberly A Roehl, et al.
Pageof 14